opdualag
bristol-myers squibb pharma eeig - nivolumab, relatlimab - Меланомът - antineoplastic agents, monoclonal antibodies - opdualag is indicated for the first line treatment of advanced (unresectable or metastatic) melanoma in adults and adolescents 12 years of age and older with tumour cell pd l1 expression < 1%.
sotyktu
bristol-myers squibb pharma eeig - deucravacitinib - псориазис - Имуносупресори - treatment of moderate-to-severe plaque psoriasis in adults.
indapen sr 1,5 mg prolonged - release tablets
pharmaceutical works polpharma sa - Индапамид - 1,5 mg prolonged - release tablets
stopress 4 mg tablets
pharmaceutical works polpharma s.a. - Периндоприл - 4 mg tablets
stopress 8 mg tablets
pharmaceutical works polpharma s.a. - Периндоприл - 8 mg tablets
atinepte 12,5 mg film - coated tablets
pharmaceutical works polpharma s.a. - 12,5 mg film - coated tablets
repitend 100 mg/ml oral solution
pharmaceutical works polpharma s.a. - 100 mg/ml oral solution
fitolizyn 3,36 g/5 g oral paste
pharmaceutical works polpharma s.a. - 3,36 g/5 g oral paste
hyposart 4 mg tablets
pharmaceutical works polpharma s.a. - 4 mg tablets
hyposart 8 mg tablets
pharmaceutical works polpharma s.a. - 8 mg tablets